Clinisys Acquires Orchard Software Clinisys today announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s…
BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced that Mikael Dolsten, M.D., Ph.D., has joined its board of directors. Dr. Dolsten, recently retired from Pfizer Inc., brings over three decades of extensive leadership and…
Claritas Rx, the leader in technology and analytics to optimize the specialty patient experience, announces the availability of its new white paper entitled “From Prescription to Abandonment: How 31% of Specialty Medications Go Unfilled Across Therapeutic Areas.” The new thought piece explores…
The National Association of Community Health Workers (NACHW) will convene its 2025 Unity Conference, bringing together hundreds of Community Health Workers (CHWs) from across the country who all work to bridge healthcare divides and improve outcomes. These frontline public health professionals serve…
Thermo Fisher Scientific, the world leader in serving science, showcases its innovations in improving clinical and diagnostic laboratory efficiency and workflow optimization during the Association for Diagnostics & Laboratory Medicine Conference (ADLM), July 27-31, 2025, in Chicago, Ill. The company…
Ant Group’s AI healthcare manager, AQ, which officially launched in June 2025, has gained 100 million users following public testing that began in September 2024. Designed to support users in managing their daily healthcare needs, AQ offers more than 100…
The groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—announced promising early results from the CARE PMR (Capturing ARIA Risk Equitably with Portable MR) study presented at the…
Bayer today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinzanetant is the first neurokinin 1 and neurokinin 3 receptor antagonist in late-stage clinical development for…
AI Medical Service’s AI-Powered Gastric Endoscopy System Gains Thai FDA Approval A medical startup focused on the development of AI diagnostic technology for endoscopy, is pleased to announce that it has received medical device approval from the Thai Food and…
Arch Insurance’s Accident & Health business unit, a leading provider of both business and consumer insurance products, is pleased to announce the launch of its new Individual Supplemental Health product suite. These products are designed to help individuals manage out-of-pocket…
Prilenia Therapeutics B.V. and Ferrer today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorization for pridopidine’s marketing authorization application for Huntington’s disease (HD). We are disappointed, but undeterred…
A Boston-based biotechnology company pioneering next-generation in vivo antibody discovery platforms, announced today a strategic collaboration with Propeller Bio, a newly launched biotechnology company focused on antibody and protein-based therapeutics. As part of the partnership, Propeller Bio will support the…